|
| 1. | 5. Antipsychotic Medications APA Practice Guidelines > TREATING BIPOLAR DISORDER: A Quick Reference Guide > C. Additional Information About Pharmacotherapeutic Agents |
|
| 2. | 5. Olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes |
|
| 3. | a) Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 5. Olanzapine |
|
| 4. | b) Implementation and dosing APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 5. Olanzapine |
|
| 5. | e. Olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Medications > 5. Antipsychotics |
|
| 6. | Efficacy of olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 1. Antipsychotic medications > b) Second-generation agents > Olanzapine |
|
| 7. | Implementation of treatment with olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 1. Antipsychotic medications > b) Second-generation agents > Olanzapine |
|
| 8. | Olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 1. Antipsychotic medications > b) Second-generation agents |
|
| 9. | Olanzapine, a second-generation antipsychotic agent, when prescribed to augment ongoing... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > C. Pharmacotherapies > 3. Miscellaneous medications |
|
| 10. | Other treatments with even more limited evidence also may be considered as monotherapies or... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition > Part A. Treatment Recommendations > II. Formulation and Implementation of a Treatment Plan > F. Approaches to Try When a First-Line Treatment Is Unsuccessful |
|
| 11. | Shared side effects of olanzapine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 1. Antipsychotic medications > b) Second-generation agents > Olanzapine |
|
| 12. | TABLE 269. Commonly used atypical and conventional antipsychotic drugs Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Indications and Efficacy |
|
| 13. | Anticholinergic side effects Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine > Risks, side effects, and their management |
|
| 14. | Atypical antipsychotics have also received attention in recent years. In one study, patients who... Textbook of Psychiatry > Chapter 12. Anxiety Disorders > Panic Disorder > Treatment > Pharmacotherapy > Other medications |
|
| 15. | Clinical use Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine |
|
| 16. | Drug interactions Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine |
|
| 17. | Hepatic effects Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine > Risks, side effects, and their management |
|
| 18. | Olanzapine Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics |
|
| 19. | Risks, side effects, and their management Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine |
|
| 20. | Seizures Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antipsychotic Medications > Atypical Antipsychotics > Olanzapine > Risks, side effects, and their management |
|